116 related articles for article (PubMed ID: 18180098)
21. PIK3CA mutation and amplification in human lung cancer.
Okudela K; Suzuki M; Kageyama S; Bunai T; Nagura K; Igarashi H; Takamochi K; Suzuki K; Yamada T; Niwa H; Ohashi R; Ogawa H; Mori H; Kitamura H; Kaneko T; Tsuneyoshi T; Sugimura H
Pathol Int; 2007 Oct; 57(10):664-71. PubMed ID: 17803655
[TBL] [Abstract][Full Text] [Related]
22. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients.
Lai YL; Mau BL; Cheng WH; Chen HM; Chiu HH; Tzen CY
Ann Surg Oncol; 2008 Apr; 15(4):1064-9. PubMed ID: 18183466
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2).
English DP; Bellone S; Cocco E; Bortolomai I; Pecorelli S; Lopez S; Silasi DA; Schwartz PE; Rutherford T; Santin AD
Am J Obstet Gynecol; 2013 Nov; 209(5):465.e1-9. PubMed ID: 23891627
[TBL] [Abstract][Full Text] [Related]
24. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma.
Oda K; Stokoe D; Taketani Y; McCormick F
Cancer Res; 2005 Dec; 65(23):10669-73. PubMed ID: 16322209
[TBL] [Abstract][Full Text] [Related]
25. Comparison of phosphatidylinositol-3-kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA.
Morrow CJ; Gray A; Dive C
FEBS Lett; 2005 Sep; 579(23):5123-8. PubMed ID: 16150444
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
[TBL] [Abstract][Full Text] [Related]
27. PIK3CA gene amplification in Japanese non-small cell lung cancer.
Kawano O; Sasaki H; Okuda K; Yukiue H; Yokoyama T; Yano M; Fujii Y
Lung Cancer; 2007 Oct; 58(1):159-60. PubMed ID: 17681398
[TBL] [Abstract][Full Text] [Related]
28. Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors.
Wu G; Mambo E; Guo Z; Hu S; Huang X; Gollin SM; Trink B; Ladenson PW; Sidransky D; Xing M
J Clin Endocrinol Metab; 2005 Aug; 90(8):4688-93. PubMed ID: 15928251
[TBL] [Abstract][Full Text] [Related]
29. PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma.
Jiang G; Huang Z; Zhang S; Wang L
Cancer Invest; 2013 Dec; 31(10):639-44. PubMed ID: 24299208
[TBL] [Abstract][Full Text] [Related]
30. PPP2R1A mutations are common in the serous type of endometrial cancer.
Nagendra DC; Burke J; Maxwell GL; Risinger JI
Mol Carcinog; 2012 Oct; 51(10):826-31. PubMed ID: 21882256
[TBL] [Abstract][Full Text] [Related]
31. Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.
Riener MO; Bawohl M; Clavien PA; Jochum W
Genes Chromosomes Cancer; 2008 May; 47(5):363-7. PubMed ID: 18181165
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
Shibata T; Kokubu A; Tsuta K; Hirohashi S
Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761
[TBL] [Abstract][Full Text] [Related]
33. PIK3CA, HRAS and KRAS gene mutations in human penile cancer.
Andersson P; Kolaric A; Windahl T; Kirrander P; Söderkvist P; Karlsson MG
J Urol; 2008 May; 179(5):2030-4. PubMed ID: 18355852
[TBL] [Abstract][Full Text] [Related]
34. The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.
Astanehe A; Finkbeiner MR; Hojabrpour P; To K; Fotovati A; Shadeo A; Stratford AL; Lam WL; Berquin IM; Duronio V; Dunn SE
Oncogene; 2009 Jun; 28(25):2406-18. PubMed ID: 19430491
[TBL] [Abstract][Full Text] [Related]
35. PIK3CA Mutations in Resected Small Cell Lung Cancer.
Han N; Cheng QY; Chen B; Cai JF; Wang XJ; Lou CJ; Qin J; Ye WW; Lei L; Lu HY
Adv Clin Exp Med; 2016; 25(3):397-402. PubMed ID: 27629725
[TBL] [Abstract][Full Text] [Related]
36. Genetic alterations in the PI3K pathway in prostate cancer.
Sun X; Huang J; Homma T; Kita D; Klocker H; Schafer G; Boyle P; Ohgaki H
Anticancer Res; 2009 May; 29(5):1739-43. PubMed ID: 19443396
[TBL] [Abstract][Full Text] [Related]
37. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
Hafner C; Vogt T; Landthaler M; Müsebeck J
Br J Dermatol; 2008 Jul; 159(1):214-7. PubMed ID: 18503601
[TBL] [Abstract][Full Text] [Related]
38. Amplification of CCND1, EMS1, PIK3CA, and ERBB oncogenes in ethmoid sinus adenocarcinomas.
Nazar G; González MV; García JM; Llorente JL; Rodrigo JP; Suárez C
Otolaryngol Head Neck Surg; 2006 Jul; 135(1):135-9. PubMed ID: 16815198
[TBL] [Abstract][Full Text] [Related]
39. Functional differences between two classes of oncogenic mutation in the PIK3CA gene.
Chaussade C; Cho K; Mawson C; Rewcastle GW; Shepherd PR
Biochem Biophys Res Commun; 2009 Apr; 381(4):577-81. PubMed ID: 19233141
[TBL] [Abstract][Full Text] [Related]
40. PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance.
Santarpia M; Altavilla G; Margeli M; Cirauqui B; Mesiti M; Cavallari V; Ramirez JL; Sanchez-Ronco M; Santarpia L; Taron M; Rosell R
Cancer Invest; 2008 Dec; 26(10):1044-51. PubMed ID: 18798071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
